Phosphorylated ribosomal S6 (p-S6) as an indicator of HER2 signaling targeted drug resistance.

609 Background: Thetargeting of HER2/neu oncoprotein with trastuzumab (Herceptin) has altered the natural history of HER2+ breast cancer, however, its clinical benefit is limited by de novo and/or ...